Ida Rousismab and Stroke

Only 20 percent of the patients used a Pixaban. The study itself and the high amount of those patients who took DOACs and got thrombolysis with it, a lot of them almost double the rate of thrombectomy. Until we have prospective randomized, I think the risk just in the abundance of cases doesn't outweigh the benefit. A review on hypertonic saline for cerebral edema is not novel; they've been using it for over a century.